McKay, Nicole S. http://orcid.org/0000-0003-4123-2548
Gordon, Brian A. http://orcid.org/0000-0003-2109-2955
Hornbeck, Russ C.
Dincer, Aylin
Flores, Shaney http://orcid.org/0000-0003-2726-8704
Keefe, Sarah J.
Joseph-Mathurin, Nelly http://orcid.org/0000-0002-9735-5152
Jack, Clifford R. http://orcid.org/0000-0001-7916-622X
Koeppe, Robert
Millar, Peter R. http://orcid.org/0000-0003-4588-739X
Ances, Beau M.
Chen, Charles D. http://orcid.org/0000-0001-6698-1268
Daniels, Alisha
Hobbs, Diana A. http://orcid.org/0000-0001-7822-6411
Jackson, Kelley
Koudelis, Deborah
Massoumzadeh, Parinaz
McCullough, Austin
Nickels, Michael L.
Rahmani, Farzaneh
Swisher, Laura
Wang, Qing
Allegri, Ricardo F. http://orcid.org/0000-0001-7166-1234
Berman, Sarah B.
Brickman, Adam M.
Brooks, William S. http://orcid.org/0000-0001-8603-4233
Cash, David M. http://orcid.org/0000-0001-7833-616X
Chhatwal, Jasmeer P. http://orcid.org/0000-0002-7792-1698
Day, Gregory S. http://orcid.org/0000-0001-5133-5538
Farlow, Martin R.
la Fougère, Christian http://orcid.org/0000-0001-7519-0417
Fox, Nick C.
Fulham, Michael http://orcid.org/0000-0003-0602-6319
Ghetti, Bernardino http://orcid.org/0000-0002-1842-8019
Graff-Radford, Neill
Ikeuchi, Takeshi http://orcid.org/0000-0001-8828-8085
Klunk, William
Lee, Jae-Hong
Levin, Johannes
Martins, Ralph
Masters, Colin L.
McConathy, Jonathan
Mori, Hiroshi
Noble, James M.
Reischl, Gerald
Rowe, Christopher
Salloway, Stephen http://orcid.org/0000-0002-2631-0942
Sanchez-Valle, Raquel
Schofield, Peter R. http://orcid.org/0000-0003-2967-9662
Shimada, Hiroyuki
Shoji, Mikio
Su, Yi http://orcid.org/0000-0002-1946-8063
Suzuki, Kazushi
Vöglein, Jonathan http://orcid.org/0000-0002-5965-838X
Yakushev, Igor
Cruchaga, Carlos http://orcid.org/0000-0002-0276-2899
Hassenstab, Jason
Karch, Celeste http://orcid.org/0000-0002-6854-5547
McDade, Eric http://orcid.org/0000-0002-6764-3866
Perrin, Richard J. http://orcid.org/0000-0002-3443-7716
Xiong, Chengjie
Morris, John C.
Bateman, Randall J. http://orcid.org/0000-0002-7729-1702
Benzinger, Tammie L. S. http://orcid.org/0000-0002-8114-0552
Brickman, Adam. M.
la Fougère, Christian
,
Article History
Received: 10 March 2022
Accepted: 15 May 2023
First Online: 10 July 2023
Competing interests
: In addition to the acknowledged granting bodies, the authors of this manuscript have received financial support from Eli Lilly (N.G.R.), Biogen (N.G.R. and C.C.), AbbVie (N.G.R. and J.L.), Eisai (C.R. and C.C.), Cerveau Technologies (C.R.) and Alector (C.C.). Consultations have been declared for Humana Healthcare (J.P.C.), Roche (N.C.F., J.L., C.R., R.S.V. and R.J.B.), Biogen (N.C.F., J.L. and C.R.), Parabon Nanolabs (G.S.D. and C.C.), DynaMed (EBSCO Health) (G.S.D.), medical testimony on legal cases pertaining to management of Wernicke encephalopathy (G.S.D.), MODAG GmbH (J.L.), Bayer Vital (J.L.), Axon Neuroscience (J.L.), Thieme Medical Publishers (J.L.), Prothena (C.R.), Wave Pharmaceuticals (R.S.V.), Janssen (R.S.V.), Neuraxpharm (R.S.V.), Blue Earth Diagnostics (I.Y.), ABX-CRO (I.Y.), ICON plc (I.Y.), Piramal (I.Y.), Eisai (R.J.B.) and Amgen (R.J.B.). Honoraria for lectures from Eisai (T.I.), Saiichi-Sankyo (T.I.), Ajinomoto (T.I.), Novartis (T.I.), Chugai (T.I.), Takeda (T.I.), Blue Earth Diagnostics (I.Y.), ABX-CRO (I.Y.), ICON plc (I.Y.) and Piramal (I.Y.). Other financial interests include owning stocks greater than $10,000 held in ANI Pharmaceuticals (G.S.D.), having a patent for PiB-PET technology (W.K.), being a member of the DIAN-TU Pharma Consortium, which includes funding and non-financial support for the DIAN-TU-001 trial from Avid Radiopharmaceuticals, Janssen, Hoffman Roche/Genentech, Eli Lilly, Eisai, Biogen, AbbVie and Bristol Myers Squibb (R.J.B. and T.L.S.B.) and royalties from C2N Diagnostics with equity ownership interest (R.J.B.). All other authors have nothing to disclose.Non-financial interests include serving on an independent data monitoring board for Roche (C.R.J.), support from Eli Lilly (N.C.F.), support from Ionis (N.C.F.), serving as director of Anti-NMDA Receptor Encephalitis Foundation (G.S.D.), member of the advisory board of Vivid Genetics (C.C.), member of the advisory board of Halia Therapeutics (C.C.), member of the advisory boards of ADx Healthcare (C.C.), Eisai (T.L.S.B.), Siemens (T.L.S.B) and a member of speaker’s bureau for Biogen (T.L.S.B.).